salicylsalicylic acid has been researched along with Lupus Erythematosus, Systemic in 1 studies
salicylsalicylic acid: structure
salsalate : A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After a patient with a history of systemic lupus erythematosus in remission was given salsalate, all of her hematologic elements, especially leukocytes, profoundly decreased within hours, although the patient was receiving steroids." | 1.29 | Salsalate-induced pancytopenia in a patient with systemic lupus erythematosus. ( Goeken, NE; Lavery, JP; Lisse, JR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lisse, JR | 1 |
| Lavery, JP | 1 |
| Goeken, NE | 1 |
1 other study available for salicylsalicylic acid and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Salsalate-induced pancytopenia in a patient with systemic lupus erythematosus.
Topics: Adolescent; Antibodies; Antibody Affinity; Antilymphocyte Serum; Female; Granulocytes; Humans; Lupus | 1993 |